Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities

被引：36

作者：

Story-Roller, Elizabeth ^{[1
]}

Maggioncalda, Emily C. ^{[1
]}

Cohen, Keira A. ^{[2
]}

Lamichhane, Gyanu ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA

来源：

FRONTIERS IN MICROBIOLOGY | 2018年 / 9卷

关键词：

Mycobacterium abscessus; beta-lactams; peptidoglycan; LD-transpeptidase; beta-lactamase inhibitor; RAPIDLY GROWING MYCOBACTERIA; VITRO ANTIMICROBIAL SUSCEPTIBILITY; NONTUBERCULOUS MYCOBACTERIA; ANTIBIOTIC SUSCEPTIBILITY; SUBSP ABSCESSUS; CYSTIC-FIBROSIS; TUBERCULOSIS L; D-TRANSPEPTIDASE; NONCLASSICAL TRANSPEPTIDASE; CLINICAL-FEATURES; CRYSTAL-STRUCTURE;

D O I：

10.3389/fmicb.2018.02273

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

beta-lactams, the most widely used class of antibiotics, are well-tolerated, and their molecular mechanisms of action against many bacteria are well-documented. Mycobacterium abscessus (Mab) is a highly drug-resistant rapidly-growing nontuberculous mycobacteria (NTM). Only in recent years have we started to gain insight into the unique relationship between beta-lactams and their targets in Mab. In this mini-review, we summarize recent findings that have begun to unravel the molecular basis for overall efficacy of beta-lactams against Mab and discuss emerging evidence that indicates that we have yet to harness the full potential of this antibiotic class to treat Mab infections.

引用

页数：10

共 50 条

[21] Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Kumar, Kartik
Daley, Charles L.
Griffith, David E.
Loebinger, Michael R.
EUROPEAN RESPIRATORY REVIEW, 2022, 31 (163):
[22] Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
Degiacomi, Giulia
Sammartino, Jose Camilla
Chiarelli, Laurent Roberto
Riabova, Olga
Makarov, Vadim
Pasca, Maria Rosalia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
[23] Dual β-lactams for the treatment of Mycobacterium abscessus: a review of the evidence and a call to act against an antibiotic nightmare
Longo, Bianca Maria
Trunfio, Mattia
Calcagno, Andrea
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (11) : 2731 - 2741
[24] Durlobactam to boost the clinical utility of standard of care β-lactams against Mycobacterium abscessus lung disease
Negatu, Dereje A.
Aragaw, Wassihun Wedajo
Gebresilase, Tewodros T.
Paruchuri, Sindhuja
Kaya, Firat
Shin, Sung Jae
Sander, Peter
Dartois, Veronique
Dick, Thomas
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2025, 69 (01)
[25] INSIGHTS INTO MYCOBACTERIUM ABSCESSUS COMPLICATIONS, NAVIGATING THE CHALLENGES IN THE INTENSIVE CARE UNT
Zorrilla, Christian Almanzar
Sekulits, Ambar
Miret, Rafael
Malhi, Manjot
Danckers, Mauricio
Bali, Sunil D.
CHEST, 2024, 166 (04) : 1261A - 1262A
[26] Macrolides and mycobacterium abscessus abscessus: A good idea
Langley, Ross John
Urquhart, Donald S.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2018, 7 (04) : 394 - 394
[27] MYCOBACTERIUM ABSCESSUS AND BRONCHIECTASIS
Ozkarafakili, M. A.
Bayraktar, B.
Baris, A.
RESPIROLOGY, 2016, 21 : 94 - 94
[28] Mycobacterium abscessus glossitis
Ko, Jae-Hoon
Kang, Cheol-In
Cho, Sun Young
Ha, Young Eun
Lee, Nam Yong
Kim, Seok Jin
Chung, Doo Ryeon
Peck, Kyong Ran
Song, Jae-Hoon
LANCET INFECTIOUS DISEASES, 2017, 17 (10): : 1098 - 1098
[29] Mycobacterium abscessus Left Ventricle Assist Device Driveline Infections: An Emerging Pathogen?
Breton, Jonatan David Nunez
Hernandez, Gabriel
Simkins, Jacques
Chaparro, Sandra Viviana
TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (05)
[30] Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates
Baranyai, Zsuzsa
Kratky, Martin
Vinsova, Jarmila
Szabo, Nora
Senoner, Zsuzsanna
Horvati, Kata
Stolarikova, Jirina
David, Sandor
Bosze, Szilvia
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 101 : 692 - 704

← 1 2 3 4 5 →